Castle Biosciences (CSTL) Profit After Tax: 2018-2025
Historic Profit After Tax for Castle Biosciences (CSTL) over the last 8 years, with Sep 2025 value amounting to -$501,000.
- Castle Biosciences' Profit After Tax fell 122.08% to -$501,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 301.42%. This contributed to the annual value of $18.2 million for FY2024, which is 131.75% up from last year.
- Latest data reveals that Castle Biosciences reported Profit After Tax of -$501,000 as of Q3 2025, which was down 111.08% from $4.5 million recorded in Q2 2025.
- Castle Biosciences' 5-year Profit After Tax high stood at $9.6 million for Q4 2024, and its period low was -$29.2 million during Q1 2023.
- For the 3-year period, Castle Biosciences' Profit After Tax averaged around -$5.5 million, with its median value being -$2.5 million (2024).
- As far as peak fluctuations go, Castle Biosciences' Profit After Tax tumbled by 1,039.38% in 2023, and later spiked by 471.71% in 2024.
- Quarterly analysis of 5 years shows Castle Biosciences' Profit After Tax stood at -$6.4 million in 2021, then tumbled by 220.65% to -$20.6 million in 2022, then soared by 87.49% to -$2.6 million in 2023, then spiked by 471.71% to $9.6 million in 2024, then plummeted by 122.08% to -$501,000 in 2025.
- Its Profit After Tax was -$501,000 in Q3 2025, compared to $4.5 million in Q2 2025 and -$25.8 million in Q1 2025.